VOLORIDGE INVESTMENT MANAGEMENT, LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1556921 JUPITER, FL

Position in ARQT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$12,734,439

-$13,808,701 QoQ

Shares Held

540,511

-40.9% QoQ

Ownership

0.432%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

VOLORIDGE INVESTMENT MANAGEMENT, LLC holds $556,290,395 across 41 Biotechnology names. ARQT ranks #15 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	189,217	$62,606,228
2	IONS	Ionis Pharmaceuticals Inc	672,858	$50,524,907
3	RVMD	Revolution Medicines, Inc.	368,325	$35,819,606
4	EXEL	Exelixis, Inc.	787,674	$33,783,337
5	BBIO	BridgeBio Pharma, Inc.	426,583	$31,678,053
6	RARE	Ultragenyx Pharmaceutical Inc.	1,426,834	$29,892,172
7	BNTX	BioNTech SE	307,864	$27,362,952
8	ASND	Ascendis Pharma A/S	114,275	$26,138,120

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,734,439	540,511	-40.9%	Shares	Sole	2026-05-15
2025-12-31	$26,543,140	914,020	+9.7%	Shares	Sole	2026-02-17
2025-09-30	$15,711,286	833,490	+982.0%	Shares	Sole	2025-11-14
2025-03-31	$1,204,827	77,035	-73.5%	Shares	Sole	2025-05-15
2024-12-31	$4,052,766	290,938	+126.5%	Shares	Sole	2025-02-14
2024-09-30	$1,194,519	128,443	-77.2%	Shares	Sole	2024-11-14
2024-06-30	$5,237,490	563,171	-40.3%	Shares	Sole	2024-08-14
2024-03-31	$9,349,757	943,467	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.